Abbott Laboratories Stock News

President Joe Biden hosted his first State of the Union Address Tuesday in front of members of Congress. In the speech, Biden discussed several items that he has already helped pass along with more fu

In the latest trading session, Abbott (ABT) closed at $120.36, marking a +1.85% move from the previous day.

Wednesday afternoon''s top analyst upgrades and downgrades included Abbott Laboratories, Camping World, Chevron, Endo International, Marathon Oil, Meta Platforms and Opendoor Technologies.

These two companies can provide consistent income to support you in your hard-earned years of retirement.

Capital Group, best known for its American Funds line of mutual funds, finally dipped a toe into the exchange-traded fund (ETF) world last week. And unlike many fund launches of the past few years, Capital Group''s ETFs aren''t chasing emerging investment themes or joining competitors in a race to zero fees. In fact, they''re delivering more of what Capital Group investors are used to: meat ''n'' potatoes. SEE MORE The 22 Best ETFs to Buy for a Prosperous 2022 These six actively managed, transparent ETFs offer a similar value proposition to the American Funds : exposure to core portfolio flavors, under the watchful eye of Capital Group''s multi-manager teams, at a reasonable cost. But to be clear: The Capital Group ETFs aren''t clones of American Funds mutual funds. They''re their own unique products, with their own separate strategies … and boast a few of the additional benefits you get from investing in an ETF wrapper. Why Now? Before we get to the products, let''s address the unashamed, neon-adorned elephant in the room: Why did Capital Group – one of the world''s largest asset managers at $2.6 trillion in assets as of the end of 2021 – wait until 2022 to finally unleash its first exchange-traded fund?

EDEN PRAIRIE, Minn., March 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO ), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients'' lives, announced the appointment of Jim Douglas as the Company''s new Chief Financial Officer (CFO) effective March 1, 2022. As CFO, Jim will lead Miromatrix''s finance organization and oversee all financial activities of the corporation. Mr. Douglas will succeed Brian Niebur, who will continue to serve Miromatrix as the Vice President of Finance. "On behalf of everyone at Miromatrix and our Board of Directors, I want to thank Brian for his many contributions during his tenure as CFO for the Company, including his strong leadership through Miromatrix''s IPO. He has played a vital role in enabling our growth and positioning us well for future financial stability," said Jeff Ross, P.h.D, Miromatrix CEO. "We appreciate his dedication and are excited that he will remain part of the Miromatrix team." "It has been a privilege to serve as Miromatrix''s CFO and to see the impact that we are making in fundamentally transforming bioengineered organs.

Abbott Laboratories recalled some Similac PM 60/40 cans and cases produced at a Michigan facility, after an infant who was exposed to the powdered baby formula died, the U.S. Food and Drug Administration (FDA) said on Monday.

A whale with a lot of money to spend has taken a noticeably bullish stance on Abbott Laboratories . Looking at options history for Abbott Laboratories (NYSE: ABT ) we detected 12 strange trades. If we consider the specifics of each trade, it is accurate to state that 58% of the investors opened trades with bullish expectations and 41% with bearish. From the overall spotted trades, 4 are puts, for a total amount of $141,140 and 8, calls, for a total amount of $1,152,545. What''s The Price Target? Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range … Full story available on Benzinga.com

DUBLIN--(BUSINESS WIRE)--The "Remote Patient Monitoring Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com''s offering. The global remote patient monitoring market reached a value of US$ 1.1 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 2.7 Billion by 2027, exhibiting a CAGR of 16.1% during 2022-2027. Companies Mentioned Abbott Laboratories AMD Global Telemedicine Inc. BIOTRONI

The market for its products is huge.

The company spun off from healthcare giant Abbott Laboratories nearly a decade ago.

The company spun off from healthcare giant Abbott Laboratories nearly a decade ago.

These stocks offer attractive dividends and more.

A whale with a lot of money to spend has taken a noticeably bearish stance on Abbott Laboratories . Looking at options history for Abbott Laboratories (NYSE: ABT ) we detected 21 strange trades. If we consider the specifics of each trade, it is accurate to state that 28% of the investors opened trades with bullish expectations and 71% with bearish. From the overall spotted trades, 5 are puts, for a total amount of $219,651 and 16, calls, for a total amount of $683,782. What''s The Price Target? Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $140.0 for Abbott Laboratories over the last 3 months. … Full story available on Benzinga.com

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.